Conference Coverage VIVA 2018 See All Content See past conferences Las Vegas, NV November 05, 2018 November 08, 2018 Drs. Juan Granada and Sahil Parikh discuss the biggest takeaways from VIVA 2018 < > No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018 News News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018 News Conference News VIVA 2018 VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease L.A. McKeown November 08, 2018 News Conference News VIVA 2018 LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation L.A. McKeown November 07, 2018 Slides Presentation VIVA 2018 TOBA II 12-Month Data Presenter: William Gray November 09, 2018 Presentation VIVA 2018 LUTONIX BTK Trial Presenter: Jihad Mustapha November 09, 2018 Presentation VIVA 2018 1-Year Outcomes for Eluvia in Long Lesions Presenter: William A. Gray November 09, 2018 @TCTMD Follow Us
No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy L.A. McKeown November 13, 2018
Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News VIVA 2018 Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention L.A. McKeown November 09, 2018
News Conference News VIVA 2018 VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease L.A. McKeown November 08, 2018
News Conference News VIVA 2018 LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation L.A. McKeown November 07, 2018
Presentation VIVA 2018 1-Year Outcomes for Eluvia in Long Lesions Presenter: William A. Gray November 09, 2018